A subset of VEGFR‐TKIs activates AMPK in LKB1‐mutant lung cancer

The mutation of tumor suppressor gene liver kinase B1 (LKB1) has a prevalence of about 20% in non–small cell lung cancer (NSCLC). LKB1‐mutant lung cancer is characterized by enhanced aggressiveness and immune escape and is associated with poor prognosis. Therefore, it is urgent to develop effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lujie, Zhang, Qin, Xiong, Yanli, Dang, Zhaoqian, Xiao, He, Chen, Qian, Dai, Xiaoyan, Zhang, Lei, Zhu, Jianwu, Wang, Dong, Li, Mengxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067398/
https://www.ncbi.nlm.nih.gov/pubmed/36459496
http://dx.doi.org/10.1111/cas.15677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067398/
https://www.ncbi.nlm.nih.gov/pubmed/36459496
http://dx.doi.org/10.1111/cas.15677

Ejemplares similares